BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 3 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $128,000 | -20.0% | 41,029 | -7.8% | 0.00% | – |
| Q3 2021 | $160,000 | +19.4% | 44,510 | +19.3% | 0.00% | – |
| Q2 2021 | $134,000 | +44.1% | 37,301 | +57.2% | 0.00% | – |
| Q1 2021 | $93,000 | +14.8% | 23,729 | +23.8% | 0.00% | – |
| Q4 2020 | $81,000 | -96.7% | 19,168 | -95.0% | 0.00% | -100.0% |
| Q4 2019 | $2,437,000 | +147.9% | 385,670 | +108.0% | 0.00% | – |
| Q1 2019 | $983,000 | +19560.0% | 185,398 | +29328.3% | 0.00% | – |
| Q2 2015 | $5,000 | -100.0% | 630 | -100.0% | 0.00% | -100.0% |
| Q1 2015 | $44,055,000 | +19.7% | 4,195,711 | +37.1% | 0.02% | +21.4% |
| Q4 2014 | $36,798,000 | -16.1% | 3,061,431 | +19.3% | 0.01% | -22.2% |
| Q3 2014 | $43,841,000 | +2263.4% | 2,565,327 | +1569.6% | 0.02% | +1700.0% |
| Q2 2014 | $1,855,000 | +209.2% | 153,652 | +50.9% | 0.00% | – |
| Q4 2013 | $600,000 | +10.7% | 101,810 | +2.1% | 0.00% | – |
| Q3 2013 | $542,000 | -37.3% | 99,745 | -53.1% | 0.00% | – |
| Q2 2013 | $864,000 | – | 212,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |